As metabolic health continues to be a major focus, innovative treatments are emerging . Retatrutide, Tirzepatide, and Semaglutide represent a remarkable generation in GLP-1 receptor agonist medications. While https://bookmarkstime.com/story22903857/the-new-drug-vs-that-medication-vs-semaglutide-a-comparative-analysis